CBD

FDA Issues Warning Letters And Test Results for Cannabidiol-Related Products

FDA has tested the chemical content of cannabinoid compounds in some of the products

Over the past several years, FDA has issued several warning letters to firms that market unapproved new drugs that allegedly contain cannabidiol (CBD). As part of these actions, FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain. It is important to note that these products are not approved by FDA for the diagnosis, cure, mitigation, treatment, or prevention of any disease. Consumers should beware purchasing and using any such products.

FirmStatePurchase Website
Honest Globe, Inc.CAelixicure.com
BioLyte Laboratories, LLCMIN/A
CannafyAZcannafyl.com
Evolved Ayurvedic Discoveries Inc./BioCBDPlusCAbiocbdplus.com

Source: FDA

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CHAMPS Smoke Shop Report, or ‘CSS’, online source for the updates and innovations on the smoke shop scene. News and information are geared strictly to accessories retail channels, with distribution limited to retailers that Smoke Shop products and wholesalers.

Newsletter

Stay informed with the most up-to-date industry news to help you grow your business: subscribe to our newsletter below!




Copyright © 2021 CHAMPS Smoke Shop Report. Terms & Conditions | Privacy Policy

To Top